Driver of GVHD after blood stem cell trans...Swiss, French and German researchers have unraveled a molecular pathway that might be useful to prevent Graft-versus-Host Disease (GVHD) in leukemic recipients of blood stem cell transplants. more ➔
Investors pool €27m for new Proteomics t...UK-based biotech startup Fluidic Analytics has raised €27m for its proteomics platform. The financing round was led by Draper Esprit, with participation from Delin Ventures, BGF, IQ Capital, and Amadeus … more ➔
Carbios set to build closed-loop PET plantFrench Carbios SA has signed a letter of intent with PVC giant Kem One to implement a demonstration plant to provide proof of concept of Carbios groundbreaking enzymatic PET depolymerisation techn … more ➔
Adrenomed bags €24m in growth financingGerman Adrenomed AG has bagged €24m in equity financing from HBM Healthcare Investments and Wellington Partners. more ➔
Roche targets asthma with inhalable JAK1 b...Researchers at Genentech have locally blocked lung inflammation in a mouse model for asthma by administration of an inhalable JAK1 inhibitor. more ➔
British F2G Biotech bags €24mThe European Investment Bank (EIB) has lent antiinfectives company F2G Biotech Ltd €24m for antifungal research and innovation under the InnovFin Infectious Diseases Finance Facility (IDFF). more ➔
Sugar replacement slows cancer growthResearchers at Cancer UK have slowed down tumour growth by simply feeding mice that carry human tumour xenografts with mannose instead of glucose. more ➔
Epigenetic drugs can increase tumour malig...Researchers at IRB Barcelona report that tumours may become more aggressive following treatment with drugs that inhibit epigenetic factors. more ➔
Forbion leads €40m financing in Inflazom...Inflammosome inhibitor specialist Inflazome Ltd has raised €40m in a Series B financing led by Forbion with co-investors Longitude Capital, Novartis Venture Fund and Fountain Healthcare Partners. more ➔
EC advisors call for update of GM legislat...The EU Commission’s Chief Scientific Advisors urge the Commission to revise the EU’s GMO Directive in order to harness gene editing. more ➔
